Purpose: Apical muscular ventricular septal defects (MVSDs), especially in small infants, can be diffi cult to manage using surgical and percutaneous closure. An intraoperative perventricular procedure is a good option for closing apical MVSDs in small children with or without associated cardiac anomalies. We evaluated the results of hybrid perventricular closure of apical MVSDs performed using an Amplatzer duct occluder (ADO). Methods: We retrospectively reviewed the medical records of 5 patients who underwent hybrid per ventricular closure of MVSDs with ADOs, from March 2006 to May 2011. The median patient age at the time of the procedure was 12 months (range, 25 days to 25 months), and the median body weight was 9.1 kg (range, 4.3 to 15 kg). Two patients had multiple ventricular septal defects (VSDs; additional peri membranous VSD in 1 patient and multiple MVSDs in the other) and 3 patients had associated cardiac anomalies; complete transposition of the great arteries in 1 patient and an atrial septal defect in 2 patients. All the procedures were performed on beating hearts, exception in 1 case. The ADO selected for the aortic side was at least 1 to 2 mm larger than the largest VSD in the left ventricle side. Results: The procedure was successful in all patients and each device was well positioned. During the median followup of 2.4 years, a small residual VSD was noted in 2 patients who had multiple VSDs and no leakage was seen in the other 3 patients. Conclusion: Perventricular closure of MVSD with an ADO is a good option for patients with apical MVSD. However, careful manipulation is important, especially in the case of small infants.
Introduction
A variety of surgical procedures have been described to close the muscular ventricular septal defects (MVSDs) 1) . But the incidence of residual defects remains high after surgery, especially if is located in the apical septum 2) . Lock et al. 3) first reported their experience of a transcatheter closure of ventricular septal defect (VSD) using a Rashkind double umbrella in 1987. After the introduction of the Amplatzer MVSD occluder (AMVSDO) in 1998, several authors [4] [5] [6] reported their initial application of the device for single muscular VSD in children and adults. Since the first report by Amin et al. 7) in 1998, a perventricular device closure of VSD has been attempted in a variety of situations such as small infants with large VSD or infants who had associated cardiac anomalies requiring surgical correction. The application of closure devices designed for implantation in an interatrial septal defect or a patent ductus arteriosus (PDA) has been sporadically reported [8] [9] [10] . The Am platzer duct occluder (ADO; AGA Medical, Golden Valley, Korean J Pediatr 2013;56(4):176-181 MN, USA) has been used to close a ruptured aneurysm of the sinus of valsalva with no untoward effect 11) . Pedra et al. 12) demonstrated the feasibility of implanting an ADO for closure of MVSD. A MVSD closure using ADO was first reported in 2005 13, 14) . Nowa days an ADO is also used for closure of perimembranous VSD (PMVSD).
In this article, we report our experience of perventricular clo sure of apical MVSD using ADO.
Materials and methods

Patients
Between March 2006 and May 2011, we performed perventri cular MVSD closures with ADO in 5 patients (3 females and 2 males) and their medical records were reviewed retrospectively. The data of the patients and their associated cardiac anomalies are described in Table 1 . Their median age was 12 months (range, 25 days to 25 months) and median body weight was 9.1 kg (range, 4.3 to 15 kg). All patients had apical MVSD or VSDs which were difficult to approach surgically and the as sociated cardiac problems requiring surgery except for one. Two patients had multiple VSDs. Three patients had associated cardiac anomalies which were complete transposition of the great arteries (TGA) in one, and atrial septal defect (ASD) in two. Three patients had previous cardiac surgery, including pulmonary artery banding in two, and PDA ligation in two patients. The size of the MVSDs on the left ventricle (LV) side, assessed by intraoperative transesophageal echocardiography (TEE), ranged from 5.0 to 7.0 mm with a median size of 6.4 mm, and the aortic disc size of the ADO ranged from 8 to 10 mm. The median ratio of ADO/defect size was 1.6 (range, 1.4 to 2.5)/1.
Methods
The technique of transcatheter closure of MVSDs that was used was similar to that described by Michel-Behnke et al. 15 ) and the procedures are described in Figs. 1, 2. All procedures were done in the operating room under general anesthesia and TEE guidance. An appropriate device size was chosen for the aortic side to be at least 1 to 2 mm larger than the maximum VSD size on the LV side. The defect size was measured by intraoperative TEE in all patients. The largest VSD was selected to close in patients who had multiple VSD. We used a larger sized ADO in patients with multiple MVSD. With the exception of one case, all procedures were performed on beating hearts without car dio pulmonary bypass (CPB). The heart was approached via a median sternotomy in four patients or subxyphoid incision in one patient who had an isolated apical MVSD. The right ventri cular (RV) puncture site was chosen by tipping the RV wall with a blunt instrument to know the way from the RV puncture site to MVSD to avoid trauma to major chordae or a papillary muscle. After passing a wire and sheath through the MVSD into the LV cavity, a purse-string suture was placed. We used a short arterial introducer as a sheath instead of an original long sheath ( Fig. 2A, B ).
The arterial introducer was selected as 1 French larger one than the recommended long sheath size for the selected ADO. The device was advanced through the short sheath into the LV and the aortic disc was deployed ( Fig. 2C ) under TEE guidance. The partially deployed occluder and sheath were pulled back to the septum ( Fig. 2D ) and configured with the pulmonic disc in the RV adjacent to the septum (Fig. 2E ). After confirmation of the device position and residual shunt, the ADO was detached and the sheath was removed (Fig. 2F) . The puncture site was closed by a purse string suture. All patients were given an anti-platelet dose aspirin for 6 months following the procedure. After device closure, surgeons performed additional procedures for the associated cardiac anomalies or problems related with previous procedures under CPB during the same session in four patients.
Result
All procedures were successful with the devices at the desired position. For early follow-up, all of patients had residual leakage upon localization of the occluder. During the follow-up (median 2.4 years) all patients were doing well with no signs of significant shunting, the initially assessed apical septal defect was completely closed in three of five patients and a small residual VSD was noted in two patients who had multiple VSDs. Addi tional procedures were performed on CPB in four patients who had associated cardiac anomalies during the same session after device closure. This included an arterial switch operation, patch closure of additional VSD, ASD closure, tricuspid valve plasty and debanding of the pulmonary artery.
There was no patient who showed LV systolic dysfunction immediately and late after the procedure. We did not much pay attention to diastolic function immediately after the procedure, but no patient showed evidence of LV diastolic dysfunction at the last echocardiography. No patient showed gross RV dys function after the procedure although we did not measure specific parameters of RV function.
One patient who had mild mitral regurgitation (MR) with mild prolapse showed gradual progression to moderate degree of MR during 6 years of follow-up. No other patient had signifi cant amount of MR after the procedure.
Two patients showed increase of QRS duration on postpro cedure No patient showed change of device position on follow-up chest X-rays or echo cardiograms.
Complications
In patient 1, the cardiology doctors were called to the operation room after surgeons had already started the CPB. Therefore, the MVSD closure was done on a nonbeating heart and we couldn't pass a guide wire through the VSD by perventricular approach. Fortunately we successfully found access to the LV from the right atrium (RA) although the MVSD could not be seen clearly from the RA. A short sheath was introduced across the tricuspid valve (TV) into the RV and finally to the LV over the guide wire.
An intraprocedural complication occurred in the patient 4 (aged 25 days and body weight was 4.3 kg). This patient had a complete TGA and multiple apical MVSD. In that patient, the short sheath went too deep in his small LV cavity, which might have aroused entanglement of the ADO aortic disc with mitral valve chordae or the LV lateral wall damage. Although we somewhat felt resistance while pulling the whole system back (Fig. 3A) , we could attach the aortic disc of the ADO to the interventricular septum. However the sheath slipped out of the heart while we pulled the sheath back to open the pulmonic side of the ADO. We thought it was at least partly because the RV puncture site was too close to the inter ventricular septum and we therefore retried at another site of the RV wall. Immediately after the successful closure of the muscular VSD, we found LV lateral wall tearing and bleeding which required surgical sutures of the LV wall. After that, he underwent an arterial switch opera tion without further problems and had postoperative course that was uneventful. An echocardiography before discharge showed pseudoaneurysm or fluid cavity at the apical area (Fig. 4A ), but LV function was good without regional wall motion abnormality. The pseudoaneurysm regressed gradually (Fig. 4B ) and disappeared at 20 months after the procedure. This patient had no significant MR after the procedure. There was no other complication during the procedure and follow-up. At a median follow-up of 2.4 years (range, 0.5 to 5 years), all patients were doing well with no signs of significant shunting (no leakage in 3 patients, minimal leakage in 2 patients). 
Discussion
How to treat a sizable apical MVSD can be a difficult decision, especially for small patients with associated cardiac problems. The surgical repair of multiple MVSDs is associated with con siderable mortality and morbidity 1, 2) . The surgical approach from the right side of the heart doesn't allow for adequate vis ualization, and this is related with significant residual of the VSD shunt 16) . The surgical approach from the LV side provides an adequate field of vision, but it requires a left ventriculotomy which is related with long-term left chamber dysfunction, arrhythmias and apical aneurysm [17] [18] [19] . Transcatheter closure of an apical MVSD is a valuable alternative to the operation. It has been proven to be effective [20] [21] [22] . However, the transcatheter closure may require the use of large venous sheaths for device delivery, and exposes small infants to the risk of peripheral vascular injury and intervening cardiac structure damage. An intraoperative perventricular procedure can be a good option for closure of apical MVSDs in small children with or without associated cardiac anomalies. A perventricular closure of MVSD was first attempted in a canine model in 1998, followed by the successful use of this device in an 8-month-old-baby by Amin et al. 7) in the same year. A perventricular device closure of apical MVSD has been described with good results [23] [24] [25] . Since Amin's first report in 1998, the AMVSDO was introduced for muscular defects not only in congenital heart defects but also effectively in postmyocardial infarction VSD [26] [27] [28] . In relation with the particular VSD shape, an ADO has been the preferred choice by some authors [29] [30] [31] . MVSD is usually smaller in the RV side as compared to the LV, and often multiple in the RV side even in case with single in the LV side. We thought, therefore, that ADO which has a trapezoidal profile and a smaller pul monic end without a RV side retention disc would be good for apical MVSD closure, especially in small infants. Also this device costs less than AMVSDO. On the other hand, the characteristics of deficient RV side retention disc of the ADO may lead to device instability or mobilization after closure of muscular VSD. We, however, presumed that device instability would not be the problem because LV pressure is higher than the RV pressure and muscular VSD size has tendency to be smaller in RV side.
In our experience, we met two technical complications for the hybrid closure of an apical MVSD. One thing is how to prevent the LV wall or mitral valve apparatus injury by the deli very system or the device. In neonates or small infants, the LV dimension is so small that safe space for manipulation during the procedure is very limited. It is essential to monitor the position of the delivery system and the device, and its relation with the LV wall and mitral valve apparatus throughout the procedure. Actually, one complication occurred for one patient who had complete TGA and multiple MVSD as well as apical MVSD. We think the LV lateral wall damage in that patient was associated with too deep an aortic disc position in the LV. In that patient, the damage could easily be repaired making this one of the benefits of the hybrid approach. Another technical issue is choosing the best location of the RV puncture site. If the punc ture site is too close to the apical MVSD, selection of VSD may be easy. However it is more difficult to keep the sheath in adequate position while pulling back the whole system after deployment of the aortic disc in the LV because the sheath can easily be slipped out of the RV. Therefore we think it is better to keep some distance from the RV puncture site to a targeted MVSD.
Although we have attempted this hybrid closure of apical MVSD primarily in patients with associated cardiac problems requiring the surgical procedure, an isolate of apical MVSD patients can have benefits from this approach such as short procedure time, avoidance of CPB, small surgical scar, and immediate handling for possible complications. The limitations of this study include a small patient sample, short follow-up, and the lack of randomization.
In conclusion, in our small series, the hybrid approach with the ADO was an effective option for apical MVSD closure. Although we should pay more attention to the delivery system and device position and select the RV puncture site more carefully in small infants, it is expected that we can do this procedure with low complication rate if only we keep several important points under consideration. With more experience, perventricular closure using an ADO can provide effective, one-stage repair in small infants with large apical MVSD and associated cardiac problems.
